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Abstract
In microbiology, successful automation means ‘fast microbiology’. As Thierry Bernard, bioMe´rieux’s Corporate Vice President of Com-
mercial Operations, put it, ‘Bugs mutate very quickly, so we have to innovate continuously to keep up with them … As we are faced
with new pathogens, microbiologists must work side-by-side to find solutions.’ Fast microbiology is based on a premise of faster results;
reducing the time needed for a result, to allow earlier and optimized patient management. Obviously, the critical component for success
is the expertise of the microbiologist at every step, validating new solutions, databases, and algorithms. Although the way in which
microbiological testing is performed may change, the essence—individualized/expert interpretation of test results and the proposal of
targeted treatments by the microbiologist—will remain.
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BioMe´rieux has always sought to work in partnership with
microbiologists to make microbiology simpler, faster and
more effective, while maintaining or improving quality. By
being at the forefront of advances in microbiology, we can
do more than offer simple, obvious solutions. We can pro-
vide complete solutions by replacing repetitive tasks with
adapted automated systems, to promptly identify diseases for
better patient care.
Picture a microbiologist whose day starts in front of a
dashboard. First, the current status of all ongoing tests in
each of the laboratories, including the satellites, are checked,
along with the status of yesterday’s results and the list of
physicians who have already received their negative results.
Then, an alert for low stock, and one for a potential hold-up
in the use of a testing instrument, are dealt with, before the
system audit report is printed out … leaving the microbiolo-
gist time to get on with the day’s important tasks: managing
the positive test results and finding solutions for issues raised
in the audit.
What this scenario describes is a system in which
standardized repetitive tasks have been removed from the
microbiologists’ ‘to do’ list. This allows them time (under
optimal conditions) to use their microbiology expertise in
interpreting tests and discussing with the treating physician,
enabling them to deliver a fast and reliable test result. The
net outcome is a shorter delay between sample testing and
high-quality results in the clinician’s hands—the primary goal
in the world of microbiology.
Full Microbiology Laboratory Automation:
Taking Automation to a Higher Level
To get the most out of automation, comprehensive inte-
gration of all automated systems may further streamline
workflow product efficiency in microbiology laboratories.
The ability to see the whole picture—from sample recep-
tion and distribution, to organism identification (ID) and
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antimicrobial resistance analysis, through to result manage-
ment and interpretation—is critical. bioMe´rieux’s Full
Microbiology Lab Automation (FMLATM) is an answer
(Fig. 1). Having bioMe´rieux working side-by-side with the
laboratory manager means that laboratory flow is opti-
mized; translating into faster results and productivity gains.
FMLA provides more rapid microbiology. It takes automa-
tion a step further, allowing laboratory managers to fulfill
their ‘lean’ objectives: increase productivity, improve trace-
ability and standardization, reduce costs, and raise manage-
ment quality. In addition, our automated solutions bring
significant advantages that facilitate the laboratory accredi-
tation process.
Intelligent Automation
Traditional microbiology includes a high fraction of low-
value-added activities by skilled technologists. Considerable
scope exists to reduce low-value work and improve technol-
ogists’ focus on critical high-skill tasks.
Technologists spend up to two-thirds of their ‘technical
time’ performing non-core tasks that could easily be
automated or eliminated through relatively simple measures.
The integration of automation in microbiology laboratories
has been surprisingly slow. This is attributable, in part, to the
importance of respecting the variability that is inherent in
the diagnostic process (specimens, containers, etc.), and the
expertise of the microbiologist.
The value of automating a task in microbiology is limited if
the ‘big picture’ is lost and the constraints of the overall pro-
cess are not taken into consideration. So what makes auto-
mation intelligent? The answer lies in targeted automation
coupled with microbiological innovations.
bioMe´rieux’s approach to automation in the microbiol-
ogy laboratory is driven by the patient, the clinician, and
the microbiologist. For both the microbiologist and the cli-
nician, time to treatment makes a critical difference for
better control of healthcare costs and patient manage-
ment.
bioMe´rieux has long been dedicated to the advancement
of scientific knowledge to empower each microbiology part-
ner to make the best decisions for their institution and com-
munity. In addition to a full range of product training,
bioMe´rieux therefore proposes a full offer aiming to facilitate
knowledge transfer, such as live presentations, webinars,
symposia, forums, and seminars.
bioMe´rieux also offers continuing education programmes,
where international courses and programmes are developed
and presented by experts in the field (Fig. 4).
Integrated Solutions in Place
Within a decade, bioMe´rieux’s automated solutions have cut
conventional test timing in half, giving microbiologists solu-
tions in hours rather than days. The next challenge is to turn
these hours into minutes. bioMe´rieux is already launching an
FIG. 1. Full Microbiology Lab Automation (FMLA). Global solution based on building a close and unique partnership with each laboratory.
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automated solution for more rapid bacterial ID: VITEK MS,
a mass spectrometry system to be used in conjunction with
a comprehensive bacterial database.
The proven VITEK 2 system provides same-day Antibiotic
Susceptibility Testing (AST) and reduces the microbiologist’s
tasks to inoculum preparation and standardization—the
system takes care of incubation, reading and traceability with
pre-applied barcodes.
VITEK MS combined with VITEK 2 provides the most
integrated solution for fast and standardized ID/AST manage-
ment.
These are but a few of bioMe´rieux’s automated solu-
tions—many others exist, such as PREVI Isola (Fig. 2), for plate
streaking with an innovative applicator (see Sidebar 1), PREVI
Color Gram, cost-effective staining technology, and UF-1000i,
fast urinary screening with flow cytometry technology.
Getting Closer to the Patient
Point-of-care/physician office aboratory testing is another
solution that takes this logic a step further—right to the
patient’s bedside for point-of-care testing. The more labora-
tories consolidate, the more point-of-care testing will
become essential.
bioMe´rieux’s recent partnership with Biocartis, to
co-develop assays on Biocartis’ fully integrated molecular
diagnostics system (sample in—result out), will allow a rapid
time to result (60–90 min) for healthcare-associated infec-
tions [Clostridium difficile, methicillin-resistant Staphylococcus
aureus, carapenem-resistant Enterobacteriaceae (CRE)] and a
valuable menu of other microbiology parameters that fits
with clinical demand.
On-site testing could revolutionize treatment. Shortening
the time from sample to result can improve treatment
options and lower the overall cost of healthcare by deliver-
ing faster and accurate results on the spot.
A United Digital World
Computerized solutions are now at the heart of today’s
leading microbiology laboratories, ensuring optimization of
microbiological management: this is the essence of bio-
Me´rieux’s FMLA. Let’s take a look into the world of
FMLA …
Myla—the pulse in your laboratory
Myla is a middleware web-based solution that integrates the
microbiology processes and delivers real-time, relevant infor-
mation for better in-process technical and clinical decisions
(Fig. 3).
Myla addresses three key optimization needs: connectivity,
workflow management, and information management.
Through a unique platform and multiple remote user
access, it provides full control of the microbiology work and
information flows. This flexible, open solution allows multiple
connections to various information systems and multiple
instruments, providing a comprehensive picture of the ongo-
ing micro-laboratory activities or patient sample data at any
point of time and any location. Alerts and messages posted
along the sample process are shared with all laboratory
stakeholders, helping them to take the right decision at the
right time.
Laboratory control at your fingertips
The intelligence of this automation is built-in flexibility—
laboratory managers can customize their dashboard to show
the most pertinent information (quality indicators, workflow
metrics, etc.) for enhanced operational management.
The result of bioMe´rieux’s full laboratory automation is
improved control and supervision of the circulation of all
data in the laboratory, and faster access to reports for track-
ing samples, infection control, instrument capacity, delayed
operations, and reagent consumption. This not only leaves
FIG. 2. Offering enhanced colony isolation, PREVI Isola improves
the turn-around time for delivery of results to the physician by
avoiding unnecessary re-incubation. The existing streaking proce-
dures waste valuable technologist time: 75% of these activities are
not core to the process outcome (providing well-streaked plates).
These could easily be automated for high-volume laboratories or
made more ergonomic in lower-volume laboratories.
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the microbiologist in an optimum position to interpret data,
but ensures that there is more time to do so.
VILINK—virtually in your laboratory
On request by the laboratory, bioMe´rieux’s customer service
teams can intervene directly on installed instruments via
VILINK, a remote-access connection (Fig. 4).
The objective is to deliver real-time higher-level support
when needed, and immediately resolve any instrument soft-
ware problems that arise. As a second step, proactive main-
tenance will be at the heart of the VILINK solution—helping
to keep your laboratory free from any breakdown.
The Microbiologist’s Perspective
So what do such advances in automation mean for today’s
microbiologists?
Not only does advanced automation allow for cost-effec-
tive patient management and a reduction in test turn-around
time, but it also tackles the problem posed by the decline in
the number of skilled laboratory technicians. The role of
technicians will evolve from manual tasks to involve a higher
level of instrument management. Automation also reduces
some of the pressure resulting from the problem of increas-
ing numbers of test samples compounded by dwindling num-
bers of microbiologists.
Consolidation of laboratories will lead to a higher compet-
itive landscape, and FMLA (with all the current and ongoing
developments) will drive the competitiveness of microbiology
laboratories.
Preparing for the Future
bioMe´rieux has also built a solid reputation with laboratory
professionals by providing a full set of services aimed at
FIG. 4. The service offered by bioMe´rieux remains a key asset for
customers, who can access to a full range of efficient and effective
solutions, both on-site and remotely.
FIG. 3. Myla at work. An innovative software solution helping to recapture your time.
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increasing laboratory productivity (instrument integration
and qualification, on-site and remote application, etc.).
To set up a lean organization, the development of skills in
technical teams is critical to the successful integration of
new automated systems in a microbiology laboratory.
By analysing specific, individual needs and providing tailor-
made high-performance solutions, lean methodologies will
help the laboratory to look at its organization from a differ-
ent perspective.
This ensures intelligent use of all laboratory resources—
technology, instruments, knowledge, and skills—to prepare for
tomorrow’s challenges today.
Tomorrow is Not so Far Away
Today, bioMe´rieux is already working closely with laboratory
technicians and managers—targeting additional areas in the
diagnostic process that can be optimized. bioMe´rieux’s step-
by-step deliverables plan is already in place.
VITEK MS: cutting-edge microbial identification
The rapid ID of microorganisms in the bloodstream has been
a major obstacle to clinicians, but now a proven method has
been adapted to the microbiology laboratory that can reduce
the time needed for ID to a few minutes.
Matrix-assisted laser desorption ionization time-of-flight
mass spectrometry can be used for rapid bacterial and
fungal ID from isolated colonies. In addition, for even
more rapid results, we are developing a procedure for
direct identification from positive blood culture via mass
spectrometry.
This approach allows reliable pathogen ID on the day of
blood culture positivity, providing treatment-relevant infor-
mation within the critical phase of sepsis or severe sepsis/
septic shock.
Another candidate for such investigations is the urine
specimen, for which Matrix-assisted laser desorption ioniza-
tion time-of-flight mass spectrometry, associated with flow
cytometry technologies, will shorten the time to result for
positive specimens.
The ultimate application for mass spectrometry is in
detecting selected resistance gene products from the sample.
Next steps for automated processes: eliminate handling
time
Obtaining colonies requires cellular multiplication on plated
media. This is a time-consuming process, because, to be
visible to the naked eye on an agar plate, colonies need
to be composed of about 5 · 107 cells. However, new
optical technologies being developed for research purposes
require, at least, one million fewer cells for colonies to be
detectable.
This obviously enables a dramatic decrease in the time
required (by at least 50%) to obtain enough colonies to
allow for ID and therapy decisions.
Ancillary ‘housekeeping’ tasks distract from high-value,
high-skill tasks during plate reading: 66% of a technologist’s
time in reading is spent on secondary or ancillary activities.
This time can be reduced significantly through simple ergo-
nomic improvements.
Improvements such as this will be feasible once three key
components—the streaking method, the culture media, and
the incubation and reading process—are optimized and inte-
grated into a smooth workflow. As the ultimate step, this
solution will enable prime performance digital imaging with a
quality exceeding the capability of the human eye—a techno-
logical solution currently under development that shows, day
after day, the benefits that it offers in making efficient deci-
sions.
This is what has led bioMe´rieux to combine process
automation with innovative microbiology—leading to a new
solution for the incubation of prepared plate medium (PPM),
and the tasks associated with this process.
As an obvious next step, the integration of the automated
preparation of elements necessary for ID and/or AST
(VITEK MS and VITEK 2) will be key to ensure a coher-
ent workflow, greater traceability, and maximum standardi-
zation.
The result is a reduction in the time needed to obtain a
result, which allows earlier therapeutic management of the
patient.
With a focus on reducing time to results, bioMe´rieux
introduced FMLA to streamline the workflow and increase
the efficiency of the microbiology laboratory, from speci-
men reception to result management and interpretation.
FMLA helps laboratories to achieve substantial productivity
gains by improving the efficiency and use of automated
systems.
Precise microbiology results constitute a powerful tool
in the hands of physicians for optimizing antibiotic treat-
ment and avoiding unnecessary expansion of resistance and
hospital-acquired infections. The more rapidly such results
are available, the greater the impact and benefit will be.
bioMe´rieux’s strategy is strongly focused on the two
essential drivers for rapid microbiology: the introduction
of new technologies that provide faster results per se, and
the seamless integration and optimization of the entire
microbiology workflow to minimize the overall turn-
around time for results. Although growth-based methods
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will continue to play an important role, especially in the
area of complex resistance mechanisms, we are taking part
today in what is probably the biggest revolution in micro-
biology since the time of Louis Pasteur. The rapid arrival
of mass spectrometry—and its immediate acceptance—is a
clear indicator of the need for more rapid results and
new solutions. Highly integrated molecular biology methods
are making their way into the routine of the microbiology
laboratory, and sequencing technologies are improving/
developing at such a speed that their use in microbiology
routine is only a matter of time. As an innovation-driven
company, bioMe´rieux is strongly engaged in all of the
above-mentioned opportunities, with the aim of always
providing the most appropriate answer to a diverse range
of needs.
The other angle of rapid microbiology is workflow inte-
gration—covering the entire range from vein to brain
(patient to physician). Matching innovative biology solutions
with intelligent image analysis and seamless handover to sub-
sequent procedures eliminates non-productive workflow
interruptions, which frequently occur outside normal work-
ing hours. At the same time, it allows the microbiologist to
focus on high-value-added activities, such as the interpreta-
tion of results and consultation. All of the skills required for
such workflow integration and acceleration (biology, infor-
matics, imaging, and advanced engineering) are working
together in our company in a truly systems-focused
approach. The ultimate goal is the achievement of (more
rapid) fast microbiology for improved/enhanced healthcare
solutions.
Sidebar 1
Today, In Vitro Diagnostics (IVDs) account for <3% of
healthcare costs. However, they provide nearly 80% of the
information used for therapy selection. The acceleration of
technology and automation, coupled with informatics and
middleware, will enable the retrieval of patient diagnostics
from anywhere in the hospital, dramatically increasing the
value of IVDs.
With an ageing population, multidrug-resistant organisms,
and laboratory consolidation, there is an increasing need for
rapid results. The decline in skilled resources is driving the
transformation to full automation and fuelling the lean labo-
ratory movement. Although there will be strong attraction
to new technologies, these solutions will need the appro-
priate regulatory clearances and financial compatibility with
hospital budgets.
Challenges to the IVD industry include financial pressures,
laboratory consolidation, and managing the capacity to offer
real medical value in compressed time frames. In addition,
the IVD industry’s challenge is to take an active role in
debating the balance between reimbursement and high-value
medical tests, while possibly decreasing reimbursement rates
for lower-value tests.
The global need to get more value from healthcare expen-
ditures will drive innovations such as theranostics, the fusion
of medicine and diagnostics. This is the cornerstone for pre-
ventive care and personalized medicine, which is becoming
more pervasive, particularly with cancer biomarkers.—Thi-
erry Bernard, Corporate Vice President, Commercial Opera-
tions, bioMe´rieux SA (Marcy l’Etoile, France).
Sidebar 2: Driving up Efficiency with Lean
Methodologies
In an already weakened economy, hospital-based microbiol-
ogy laboratories are under increased pressure to provide
the highest-quality patient test results. This pressure results
from several factors, including same-day test results being
demanded by physicians, an increasing number of test sam-
ples [legislation requiring Healthcare Associated Infections
(HAI) screening, increasing organism resistance, etc.], addi-
tional testing menus based on new technologies (molecular
testing), and limited laboratory budgets. Unlike other labora-
tory departments, such as chemistry and haematology, the
microbiology laboratories still rely on manual and subjective
procedures to perform many of their routine tests. An esti-
mated 40–50% of a microbiologist’s current time is spent on
administrative and other manual tasks, where they use little,
if any, of their technical expertise. The amount of time that
laboratory technologists spend in cycling paperwork, per-
forming unnecessary tests or walking from bench to bench
can be costly in terms of waste and money, with inefficiency
being one of the largest drivers of waste.
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Lean methodology ensures that laboratories continue to
meet strict regulatory issues without having to compromise
quality control, turn-around times, or performance. Lean
methodology helps laboratory workers and management to
find better ways of increasing productivity and efficiency
without driving up costs and impeding workflow.
Ron Wince, President and CEO, Guidon Performance
Solutions.
Transparency Declaration
None to declare.
CMI Mulatero et al. Full Microbiology Laboratory Automation 667
ª2011 bioMe´rieux
Clinical Microbiology and Infection ª2011 European Society of Clinical Microbiology and Infectious Diseases, CMI, 17, 661–667
